SONOVA (OTCMKTS:SONVY) Upgraded at Zacks Research

Zacks Research upgraded shares of SONOVA (OTCMKTS:SONVY) from a strong sell rating to a hold rating in a research note issued to investors on Thursday,Zacks.com reports.

A number of other equities research analysts have also weighed in on the stock. BNP Paribas lowered shares of SONOVA from a “strong-buy” rating to a “strong sell” rating in a report on Wednesday, June 11th. Sanford C. Bernstein upgraded shares of SONOVA from a “hold” rating to a “strong-buy” rating in a report on Friday, July 18th. Kepler Capital Markets upgraded shares of SONOVA from a “strong sell” rating to a “hold” rating in a report on Friday, June 6th. HSBC lowered shares of SONOVA from a “buy” rating to a “hold” rating in a report on Wednesday, May 21st. Finally, Hsbc Global Res downgraded shares of SONOVA from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 21st. One research analyst has rated the stock with a Strong Buy rating, four have issued a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce”.

SONOVA Price Performance

Shares of SONVY opened at $58.36 on Thursday. SONOVA has a twelve month low of $52.83 and a twelve month high of $77.56. The firm’s fifty day simple moving average is $57.55 and its 200-day simple moving average is $60.16. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.96 and a current ratio of 1.27.

SONOVA Increases Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, July 2nd. Shareholders of record on Tuesday, June 17th were given a dividend of $0.6243 per share. This represents a yield of 99.0%. The ex-dividend date of this dividend was Monday, June 16th. This is an increase from SONOVA’s previous dividend of $0.57.

About SONOVA

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.